I'm entering longs here, averaging in gradually. I anticipate a monthly scale rally, back to 54.59 possibly, coming off a double bottom at key support, with an extremely low valuation, and positive news regarding breakthroughs in delaying drug metabolism. Good luck! Ivan Labrie
The $TEVA chart just keeps getting better and better.... Quarterly chart is rejecting last 2 major lows with a pinbar with stoch RSI overbought Ideally we bounce here to retest the fibs and form a right shoulder before complete capitulation. If the H&S formation is confirmed $TEVA should head down to levels we haven't seen since the 90's ($10 and below)
There are a few names popping up on my radar for earnings plays, but when I "look behind the curtain," they aren't that attractive ... . TEVA, for example, announces on Monday, but it's an ADR, so it could be before market open or after market close or, indeed, not at all, but on some other day. It's tough to put on a volatility contraction play when you don't...
Shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) plummeted after-hours Monday after four patents on Copaxone were invalidated. The stock fell as much as 10% to nearly $31. Teva Pharmaceuticals has been under pressure for months from government threats of drug price curbs. The stock is trading at 10 year lows. I am alerting investors that there is major...
We appear to be bottoming at the neckline of a potential H&S. This thing is a monster and can be easily seen on the 6 month and yearly time frames. You could buy the relief rally that takes us back up or wait for extra confirmation and sell the relief rally with a formation of that shoulder.
Swing Trading long TEVA in NYSE on extreme oversold condition & Hammer reversal candlestick
No position yet. Refer to chart:) If you have any thoughts about this company, please leave in the comments:)
Selling the 47.5 put naked here below support as a potential precursor to a covered call, which I got filled for a .73 ($73)/contract credit. Basically, my thought process here is that I might want to covered call TEVA, but don't want to buy shares here at 53 (lower is better). I'll naturally watch price and roll the short put down and out for a credit should it...
Post-earnings, TEVA's implied volatility rank/implied volatility are still quite high, and the 47.5/60 short strangle goes for 1.58 ($158)/contract at the mid. Look to take it off at 50% max profit ... . Defined Risk Alternative: Sept 16th 42.5/47.5/60/65 iron condor, currently going for 1.13 ($113)/contract at the mid.
With broad market volatility ebbing, the place to sell premium is with earnings plays for now. Next week, look to put on options plays shortly before the earnings announcement to capitalize on post-announcement volatility contraction. This little fellahs currently look best for plays: LC: 5/9 (Monday) after market close. Due to the price of the underlying,...
TEVA had a couple of failed breakdowns below support, and appears to be moving upward.
Hello everyone, we have a potential pattern on this pair along with the structure . The targets are highlighted on the chart with two PRZ's. Good Luck For info: kevinsdhaliwal@hotmail.com Twitter: kevindhaliwal1 Instagram: AllTradingIdeas
I am watching to Teva for long time when price was going in trading range. Teva break up the 2 years old resistance. Now it looks like trading range again. My target is around 62-63 USD per share.